Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Dermatomycosis

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44339   clinical trials with a EudraCT protocol, of which   7369   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    Query did not match any clinical trials.
    These are paediatric studies completed by 26 January 2007, in respect of products authorised in the Community (Article 45 of the Paediatric Regulation (EC) No 1901/2006).
    Note: Advanced search filters for country, trial phase, gender, rare disease, IMP with orphan designation in the indication and age ranges of in-utero, adult or elderly do not apply to these records.
    Study title: Efficacy and tolerability of bifonazole cream 1% and solution 1% in dermatomycosis.
    Active substance: BIFONAZOLE
    Study summary document link (including results): Bifonazole_0399.pdf
    View full study record
    Document reference: 47218
    Study title: Efficacy and tolerability of bifonazole cream 1% and solution 1% in dermatomycosis
    Active substance: BIFONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 22411
    Study title: Efficacy and tolerability of bifonazole cream 1% and solution 1% in dermatomycosis
    Active substance: BIFONAZOLE
    Study summary document link (including results): Bayer CC_Bifonazole_0340_study_synopsis.pdf
    View full study record
    Document reference: 22417
    Study title: EFFICACY AND SAFETY OF ORAL FCA IN THE TREATMENT OF DERMATOMYCOSIS, OPEN NON COMPARATIVE STUDY.
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 27655
    Study title: EFFICACY AND SAFETY OF ORAL FCA IN THE TREATMENT OF DERMATOMYCOSIS, OPEN NON COMPARATIVE STUDY.
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 28017
    Study title: EFFICACY AND SAFETY OF ORAL FLUCONAZOLE IN THE TREATMENT OF DERMATOMYCOSIS. OPEN NON-COMPARATIVE STUDY.
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 27656
    Study title: EFFICACY AND SAFETY OF ORAL FLUCONAZOLE IN THE TREATMENT OF DERMATOMYCOSIS. OPEN NON-COMPARATIVE STUDY.
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 28018
    Study title: EFFICACY AND SAFETY OF ORAL FLUCONAZOLE IN THE TREATMENT OF DERMATOMYCOSIS. OPEN NON-COMPARATIVE STUDY.
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 27654
    Study title: EFFICACY AND SAFETY OF ORAL FLUCONAZOLE IN THE TREATMENT OF DERMATOMYCOSIS. OPEN NON-COMPARATIVE STUDY.
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 28016
    Study title: A RANDOMIZED, DOUBLE-BLIND MULTICENTER STUDY OF THE ASSESSMENT OF CLINICAL EFFICACY AND SYSTEMIC SAFETY OF FCA 50MG AND 100MG CAP VS. ITRACONAZOLE 100MG CAP IN TREATMENT OF DERMATOMYCOSIS.
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 27468
    Study title: A RANDOMIZED, DOUBLE-BLIND MULTICENTER STUDY OF THE ASSESSMENT OF CLINICAL EFFICACY AND SYSTEMIC SAFETY OF FCA 50MG AND 100MG CAP VS. ITRACONAZOLE 100MG CAP IN TREATMENT OF DERMATOMYCOSIS.
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 27832
    Study title: Alcantara R. Treatment of dermatomycosis with 100 mg itraconazole o.d. during fifteen or thirty days. Janssen Research Foundation Products Information service. Clinical research report, February 1988. (5-90 years, LMD59929)Alcantara R. Treatment of dermatomycosis with 100 mg itraconazole o.d. during fifteen or thirty days. Janssen Research Foundation Products Information service. Clinical research report, February 1988. (5-90 years, LMD59929)
    Active substance: ITRACONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 30779
    Study title: Decroix J, et al Oral itraconazole in the treatment of dermatomycosis. A multicenter evaluation of different treatment schedules. Clinical summary on R51211, August 1987. (10-86 years, LMD56447)Decroix J, et al Oral itraconazole in the treatment of dermatomycosis. A multicenter evaluation of different treatment schedules. Clinical summary on R51211, August 1987. (10-86 years, LMD56447)
    Active substance: ITRACONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 30789
    Study title: Treatment of Dermatomycosis with Tioconazole 2% Dermal Cream
    Active substance: TIOCONAZOLE
    Study summary document link (including results): TCN-MEX-87-001 EMA Pediatrics Web Synopsis.pdf
    View full study record
    Document reference: 48035
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Mon Jun 02 07:28:00 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA